Reuters logo
BRIEF-Ionis earns $40 million Spinraza regulatory milestone payment from Biogen
August 30, 2017 / 11:14 AM / 3 months ago

BRIEF-Ionis earns $40 million Spinraza regulatory milestone payment from Biogen

Aug 30 (Reuters) - Ionis Pharmaceuticals Inc

* Ionis earns $40 million Spinraza regulatory milestone payment from Biogen

* Ionis Pharmaceuticals Inc - ‍earned a $40 million milestone payment from Biogen associated with pricing approval of Spinraza in Japan​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below